- Home
- About Us
- Industry
- Innovation
- Market
- Products
-
Responsibility
Responsibility
-
Contact
Contact
Categroies
1/1
Number of views:
1000
Sorafenib tosylate
2. Treatment of primary hepatocellular carcinoma that is inoperable or distantly metastasized.
Retail price
0.0
元
Market price
0.0
元
Number of views:
1000
Product serial number
Category
Antitumor
Quantity
-
+
Stock:
0
1
Details
Cas No.:
475207-59-1
Indication:
1. Treatment of inoperable advanced renal cell carcinoma.
2. Treatment of primary hepatocellular carcinoma that is inoperable or distantly metastasized.
1. Treatment of inoperable advanced renal cell carcinoma.
2. Treatment of primary hepatocellular carcinoma that is inoperable or distantly metastasized.
Previous
None
Next
Dabrafenib
keyword：Chemical products，Chinese medicine products
Related products
Inquiry
Mobile
+8613637076726 
Contact 